RT Journal Article
SR Electronic
T1 Review of the Psoriatic Arthritis Working Group at OMERACT 12: A Report from the GRAPPA 2014 Annual Meeting
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1048
OP 1051
DO 10.3899/jrheum.150131
VO 42
IS 6
A1 William Tillett
A1 Lihi Eder
A1 Niti Goel
A1 Maarten de Wit
A1 Alexis Ogdie
A1 Ana-Maria Orbai
A1 Willemina Campbell
A1 Oliver FitzGerald
A1 Neil J. McHugh
A1 Dafna D. Gladman
A1 Vibeke Strand
A1 Philip J. Mease
YR 2015
UL http://www.jrheum.org/content/42/6/1048.abstract
AB At the 2014 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the psoriatic arthritis (PsA) working group of OMERACT (Outcome Measures in Rheumatology) presented a review of the progress made at the OMERACT 12 meeting, held in 2014. Members of the PsA OMERACT working group presented work from the Patient Involvement in Outcome Measures for PsA initiative to improve the incorporation of patient research partners in PsA outcomes research, the results of discussions within the OMERACT breakout groups, and finally the voting results. The OMERACT 12 participants had endorsed the need to update the PsA core set according to the Filter 2.0 framework. The breakout group discussions identified potential opportunities for revising the core set, including consolidating existing redundancy within the core set, improving incorporation of the patient perspective, and including disease effects such as fatigue as a core criterion. GRAPPA members of the OMERACT working group now have a program of research to update the core set with the goal of seeking endorsement at OMERACT 13, to be held in 2016.